West Branch Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Sell |
2,699
-309
| -10% | -$125K | 0.32% | 47 |
|
|
2025
Q1 | $1.5M | Buy |
3,008
+296
| +11% | +$147K | 0.5% | 40 |
|
|
2024
Q4 | $1.41M | Sell |
2,712
-40
| -1% | -$20.8K | 0.45% | 39 |
|
|
2024
Q3 | $1.7M | Buy |
2,752
+68
| +3% | +$42.1K | 0.59% | 34 |
|
|
2024
Q2 | $1.48M | Buy |
2,684
+195
| +8% | +$108K | 0.55% | 35 |
|
|
2024
Q1 | $1.45M | Buy |
2,489
+339
| +16% | +$197K | 0.58% | 33 |
|
|
2023
Q4 | $1.14M | Sell |
2,150
-89
| -4% | -$47.3K | 0.54% | 33 |
|
|
2023
Q3 | $1.13M | Buy |
2,239
+138
| +7% | +$69.9K | 0.59% | 33 |
|
|
2023
Q2 | $1.1M | Buy |
2,101
+43
| +2% | +$22.4K | 0.55% | 33 |
|
|
2023
Q1 | $1.19M | Buy |
2,058
+5
| +0.2% | +$2.88K | 0.66% | 31 |
|
|
2022
Q4 | $1.13M | Hold |
2,053
| – | – | 0.7% | 32 |
|
|
2022
Q3 | $1.04M | Sell |
2,053
-42
| -2% | -$21.3K | 0.65% | 38 |
|
|
2022
Q2 | $1.14M | Sell |
2,095
-4
| -0.2% | -$2.17K | 0.66% | 38 |
|
|
2022
Q1 | $1.24M | Sell |
2,099
-94
| -4% | -$55.5K | 0.59% | 39 |
|
|
2021
Q4 | $1.46M | Buy |
2,193
+216
| +11% | +$144K | 0.62% | 37 |
|
|
2021
Q3 | $1.13M | Buy |
1,977
+37
| +2% | +$21.1K | 0.54% | 42 |
|
|
2021
Q2 | $979K | Sell |
1,940
-33
| -2% | -$16.7K | 0.48% | 44 |
|
|
2021
Q1 | $901K | Sell |
1,973
-60
| -3% | -$27.4K | 0.53% | 45 |
|
|
2020
Q4 | $947K | Buy |
2,033
+155
| +8% | +$72.2K | 0.56% | 44 |
|
|
2020
Q3 | $829K | Buy |
1,878
+277
| +17% | +$122K | 0.53% | 45 |
|
|
2020
Q2 | $580K | Buy |
+1,601
| New | +$580K | 0.41% | 53 |
|